The functional mechanisms of NHE-9 activators encompass a variety of biochemical and cellular pathways, each contributing to the modulation of NHE-9's activity in specific contexts. Compounds such as Amiloride and its derivative EIPA directly target Na+/H+ exchange processes, closely linked to NHE-9's role in maintaining cellular ion balance and pH regulation. By influencing sodium transport, these compounds indirectly enhance NHE-9's functional activity in cellular environments where ion exchange and pH maintenance are critical. Similarly, Bafilomycin A1 and Ouabain, through their distinct actions on H+-ATPase and Na+/K+-ATPase respectively, create ionic and pH conditions that are conducive to the functional enhancement of NHE-9. These alterations in intracellular ionic landscapes are essential for the optimal operation of NHE-9 in processes such as endosomal pH regulation and ion transport.
Further, compounds like Furosemide, Hydrochlorothiazide, and Verapamil indirectly modulate NHE-9 activity by influencing the overall ionic balance and calcium dynamics within cells. These changes in ion concentrations and signaling molecules create a cellular milieu that can enhance NHE-9's functionality. Forskolin and Genistein, on the other hand, act through the modulation of cellular signaling pathways. Forskolin's role in elevating cAMP levels and Genistein's inhibition of tyrosine kinases lead to a cascade of events affecting various ion transporters, including NHE-9. Additionally, KN-93 and PD98059, by targeting key enzymes in calcium signaling and the MAPK pathway, respectively, further elucidate the complex network of intracellular signaling that indirectly enhances NHE-9's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
EIPA, a derivative of amiloride, specifically inhibits certain Na+/H+ exchangers, potentially affecting NHE-9 activity in cellular sodium balance and pH regulation. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain, a cardiac glycoside inhibiting Na+/K+-ATPase, could affect NHE-9 function by altering sodium and potassium gradients, crucial for NHE-9 regulated ion transport. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Furosemide, a loop diuretic affecting sodium transport, could indirectly modulate NHE-9 activity by altering the ionic balance in cells, a factor important for NHE-9 function. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
Hydrochlorothiazide, a thiazide diuretic influencing sodium transport, can indirectly affect NHE-9's role in ion exchange and pH regulation. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil, a calcium channel blocker, may indirectly influence NHE-9 activity by modulating intracellular calcium levels, which can affect various ion transport processes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an activator of adenylate cyclase, increases cAMP levels, potentially affecting NHE-9 activity by influencing cellular signaling pathways related to ion transport and pH balance. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, can indirectly affect NHE-9 by modulating signaling pathways that influence ion transport and cellular pH regulation. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93, an inhibitor of Ca2+/calmodulin-dependent protein kinase II, could influence NHE-9 function by affecting calcium signaling pathways, crucial for ion transport regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, can indirectly influence NHE-9 by modulating cellular stress responses, which are known to affect ion transporter activities. | ||||||